Dr. Sara Torgerson Joins Minnesota Oncology

Minnesota Oncology is pleased to announce the addition of Sara Torgerson,  D.O. to the Medical  Oncology & Hematology practice at the St. Paul Cancer Center beginning today.

“It is a privilege to care for my patients and of utmost importance to appreciate their unique circumstances.  I endeavor to provide compassionate, patient-centered care while offering the latest evidence-based medical treatment,” says Dr. Torgerson.  

Dr. Torgerson received her medical degree from Des Moines University College of Osteopathic Medicine.  She completed a residency in internal medicine and a fellowship in medical oncology & hematology at the Medical College of Wisconsin, Milwaukee.  Dr Torgerson also holds a Bachelor of Science degree from The College of William and Mary, Williamsburg, VA. Her areas of special interest are breast cancer, lung cancer, solid tumors, and blood disorders.

She has presented at regional meetings as well as international lung cancer conferences and has written several peer reviewed articles, including a recent review on supportive care for pancreatic cancer patients.

In her spare time, Dr. Torgerson says she enjoys being with her husband and two young children, Charlotte and Christian.  "I also love downhill skiing and water sports," she says. "In the summer my favorite getaway is the family’s lake cabin in Wisconsin."

Appointments can be scheduled with Dr. Torgerson at the St. Paul Cancer Center by calling (651) 251-5500.

Share

Categories

Tags

Recent Posts

#
May 19, 2025

Exposure to bacteria may contribute to rising rates of colorectal cancer in young adults. Colorectal cancer has moved from being the fourth leading of cause of cancer related death in both men and women under the age of 50 two decades ago to being number one in men and second in women.

#
May 15, 2025

Spiritual care is a type of support within healthcare that addresses a person's spiritual, existential, and emotional needs, often in times of illness or crisis.

#
May 14, 2025

Bladder cancer is one of the most common cancers. Nearly 84,000 new cases will be diagnosed in the U.S. in 2021.